Atomoxetine Hydrochloride

Atomoxetine (brand name Strattera) is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD).This compound is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera.

Online Inquiry

CAT#10-101-111
CAS82248-59-7
Synonyms/AliasLY-135252; LY-139602; LY-139603; Tomoxetine Hydrochloride; (R)-(-)-N-Methyl-3-(o-tolyloxy)-3-phenylpropylamine · HCl; (R)-(-)-N-Methyl-γ-(2-methylphenoxy)-benzenepropanamine · HCl
Chemical Name(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride
M.F/FormulaC17H21NO · HCl
M.W/Mr.291.82
Labeling TargetNorepinephrine (NE) transporter;
5-HT;
DA transporters
ApplicationAttention deficit hyperactivity disorder (ADHD)
AppearanceSolid powder
Purity>98% (or refer to the Certificate of Analysis)
ActivityInhibitor
Areas of InterestNeurological Disease
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Contact Us

Address:

Tel: |

Email:

Copyright © 2022 Creative Peptides. All rights reserved.